Adenosine A2A-R Antibodies

Santa Cruz Biotechnology features a diverse variety of Adenosine A2A-R monoclonal antibodies for investigating the adenosine A2A receptor in various biological processes. Adenosine A2A-R monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The adenosine A2A receptor is a G protein-coupled receptor that mediates adenosine effects, influencing processes such as neurotransmission, immune response, and cardiovascular function. Adenosine A2A-R has emerged as a significant focus in research due to its involvement in various pathophysiological conditions, including neurodegenerative diseases and cancer. Research on Adenosine A2A-R continues to reveal new insights about its role in cellular signaling pathways and physiological responses. Understanding Adenosine A2A-R function can lead to breakthroughs in therapeutic strategies and drug development. Investigating the molecular mechanisms of Adenosine A2A-R helps advance knowledge in both basic research and clinical applications. The extensive selection of Adenosine A2A-R monoclonal antibodies from Santa Cruz Biotechnology enables researchers worldwide to conduct precise and reliable experiments, contributing to scientific advancement in receptor biology and drug discovery.